sertraline has been researched along with Cardiometabolic Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ben-Shushan, G; Gil-Ad, I; Hershkovitz, A; Isaac, R; Levkovitz, Y; Ronen, D; Shvartsman, D; Weizman, A; Zick, Y | 1 |
Al-Zaman, Y; Aylwin, S | 1 |
1 review(s) available for sertraline and Cardiometabolic Syndrome
Article | Year |
---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
1 other study(ies) available for sertraline and Cardiometabolic Syndrome
Article | Year |
---|---|
Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases.
Topics: Animals; Cell Line, Tumor; Diabetes Mellitus; Enzyme Activation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Metabolic Syndrome; Paroxetine; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Selective Serotonin Reuptake Inhibitors; Serine; Sertraline; Signal Transduction | 2007 |